Company profile for Thermosome

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Thermosome is a German biotech company developing targeted cancer therapies using thermosensitive liposomes combined with regional hyperthermia. Their lead drug, THE001 (a temperature-sensitive doxorubicin), is in Phase I trials for soft tissue sarcoma and has shown promising safety and efficacy. The approach boosts local drug delivery up to 15x without harming healthy tissue. THE001 has orphan drug designation from both the F...
Thermosome is a German biotech company developing targeted cancer therapies using thermosensitive liposomes combined with regional hyperthermia. Their lead drug, THE001 (a temperature-sensitive doxorubicin), is in Phase I trials for soft tissue sarcoma and has shown promising safety and efficacy. The approach boosts local drug delivery up to 15x without harming healthy tissue. THE001 has orphan drug designation from both the FDA and EMA.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Am Klopferspitz 1982152 Planegg
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty